[SYRE] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Dec-2019
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 0.36%
YoY- -44.28%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 168 3,644 0 0 0 1,482 1,247 -28.39%
PBT -18,784 -20,423 -22,714 -21,495 -14,898 -6,483 -5,483 22.76%
Tax 38 23 0 0 0 0 0 -
NP -18,822 -20,446 -22,714 -21,495 -14,898 -6,483 -5,483 22.81%
Tax Rate - - - - - - - -
Total Cost 18,990 24,090 22,714 21,495 14,898 7,965 6,730 18.86%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -11,203.57 -561.09 0.00 0.00 0.00 -437.45 -439.70 71.49%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -7.20 -10.36 0.00 0.00 0.00 0.00 0.00 -
EPS Diluted -7.20 -10.36 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.